Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Alessandro Imparato"'
Autor:
Alessandro Mezzani, Massimo Pistono, Piergiuseppe Agostoni, Andrea Giordano, Marco Gnemmi, Alessandro Imparato, Pierluigi Temporelli, Ugo Corrà
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0187112 (2018)
Exercise ventilation/perfusion matching in continuous-flow left ventricular assist device recipients (LVAD) has not been studied systematically. Twenty-five LVAD and two groups of 15 reduced ejection fraction chronic heart failure (HFrEF) patients wi
Externí odkaz:
https://doaj.org/article/93341e5bf2fc48909eecbce765d3ee13
Autor:
Massimo Pistono, Ugo Corrà, Marco Gnemmi, Alessandro Imparato, Roberto Caruso, Gianluigi Balestroni, Franco Tarro Genta, Elisabetta Angelino, Pantaleo Giannuzzi
Publikováno v:
Monaldi Archives for Chest Disease, Vol 76, Iss 3 (2015)
Over the years left ventricular assist devices (VADs) have become more durable and reliable, smaller, simpler, easier to implant and more comfortable. The extensive experience now acquired shows successful hospital discharge with VAD use. We are ente
Externí odkaz:
https://doaj.org/article/47c04bb345404a3197d73eae6ece504c
Publikováno v:
European Journal of Preventive Cardiology. 25:1838-1842
Background Exercise oscillatory ventilation is an ominous outcome sign in heart failure due to reduced left ventricular ejection fraction; currently, the prevalence of exercise oscillatory ventilation is unknown in left ventricular assist device reci
Autor:
Mauro Rinaldi, Alessandro Imparato, Elena Canal, Andrea Giordano, Alessandro Mezzani, Ugo Corrà, Marco Gnemmi, Massimo Pistono, Pantaleo Giannuzzi, Paolo Centofanti, Silvia Colombo
Publikováno v:
IJC Heart & Vessels. 4:40-45
BackgroundIn continuous-flow left ventricular assist device (LVAD) recipients, little is known about the relative pump- and left ventricle-generated blood flow (PBF and LVBF, respectively) contribution to peak systemic perfusion during incremental ex
Autor:
Alessandro Imparato, Pantaleo Giannuzzi, Ermanno Eleuteri, Pier Luigi Temporelli, Francesco Scapellato
Publikováno v:
Circulation: Heart Failure. 3:387-394
Background— Although several studies have demonstrated a good correlation between Doppler echocardiographic and invasive measurements of single hemodynamic variables, the accuracy of echocardiography in providing a comprehensive assessment in indiv
Autor:
L. Brentana, Massimo Pistono, Francesco Patanè, E. Zingarelli, Pantaleo Giannuzzi, Pier Luigi Temporelli, Alessandro Imparato, Marco Gnemmi
Publikováno v:
International Journal of Cardiology. 131:e120-e123
In heart transplant recipients, the aetiology of coronary vasospasm is largely unknown but it has been reported to be related to coronary vasculopathy or allograft rejection. We report a case of acute, reversible coronary vasospasm which caused malig
Autor:
Alessandro Imparato, Enzo Bosimini, Francesco Scapellato, Ugo Corrà, Pantaleo Giannuzzi, Alessandro Mezzani
Publikováno v:
American Heart Journal. 143:418-426
Peak oxygen consumption (VO2) has an important prognostic role in chronic heart failure (CHF), but its discriminatory power is limited in patients with intermediate exercise capacity (peak VO2 between 10-18 mL/kg/min). Thus, supplementary exertional
Autor:
Alessandro Imparato, Massimo Pistono, Pantaleo Giannuzzi, L. Brentana, Ugo Corrà, Marinella Gattone, Marco Gnemmi, Pier Luigi Temporelli
Publikováno v:
International Journal of Cardiology. 122:e18-e20
Brain natriuretic peptide (BNP) is commonly used for diagnosis and prognosis of patients with congestive heart failure (HF). High levels of BNP are associated with high probability of cardiogenic dyspnea and higher risk of subsequent cardiovascular e
Autor:
Marco Gnemmi, Franco Tarro Genta, Alessandro Imparato, Pantaleo Giannuzzi, Pier Luigi Temporelli, Ugo Corrà, Massimo Pistono
Publikováno v:
International journal of cardiology. 168(6)
Ventricular assist device (VAD) technology has rapidly evolved, and VADs are now seen as a reliable lifesaving option to support the failing heart in the short- and long-term: in some cases, VAD therapy represents a well-accepted treatment option for
Publikováno v:
Journal of the American College of Cardiology. 28:383-390